Akso Health Group (AHG)
1.48
+0.09
(+6.47%)
USD |
NASDAQ |
Jun 10, 16:00
1.48
0.00 (0.00%)
After-Hours: 17:13
Akso Health Group Enterprise Value : 31.28M for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 31.28M |
| June 08, 2026 | 30.31M |
| June 05, 2026 | 30.47M |
| June 04, 2026 | 32.42M |
| June 03, 2026 | 32.26M |
| June 02, 2026 | 32.26M |
| June 01, 2026 | 32.91M |
| May 29, 2026 | 33.40M |
| May 28, 2026 | 33.72M |
| May 27, 2026 | 34.05M |
| May 26, 2026 | 34.70M |
| May 22, 2026 | 33.56M |
| May 21, 2026 | 33.24M |
| May 20, 2026 | 34.70M |
| May 19, 2026 | 35.19M |
| May 18, 2026 | 36.82M |
| May 15, 2026 | 36.82M |
| May 14, 2026 | 41.86M |
| May 13, 2026 | 40.07M |
| May 12, 2026 | 43.08M |
| May 11, 2026 | 43.00M |
| May 08, 2026 | 40.88M |
| May 07, 2026 | 42.02M |
| May 06, 2026 | 42.02M |
| May 05, 2026 | 44.46M |
| Date | Value |
|---|---|
| May 04, 2026 | 43.49M |
| May 01, 2026 | 43.49M |
| April 30, 2026 | 44.30M |
| April 29, 2026 | 45.11M |
| April 28, 2026 | 46.58M |
| April 27, 2026 | 46.25M |
| April 24, 2026 | 41.78M |
| April 23, 2026 | 43.16M |
| April 22, 2026 | 40.88M |
| April 21, 2026 | 40.88M |
| April 20, 2026 | 40.72M |
| April 17, 2026 | 41.21M |
| April 16, 2026 | 43.32M |
| April 15, 2026 | 44.63M |
| April 14, 2026 | 47.07M |
| April 13, 2026 | 48.53M |
| April 10, 2026 | 45.93M |
| April 09, 2026 | 45.44M |
| April 08, 2026 | 45.93M |
| April 07, 2026 | 45.77M |
| April 06, 2026 | 45.28M |
| April 02, 2026 | 44.79M |
| April 01, 2026 | 46.42M |
| March 31, 2026 | 45.77M |
| March 30, 2026 | 46.90M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Interpace Biosciences, Inc. | 46.63M |
| Sinovac Biotech Ltd. | -32.96M |
| China Pharma Holdings, Inc. | 32.38M |
| CASI Pharmaceuticals, Inc. | 23.96M |
| China Medicine Corp. | -- |
Enterprise Value Related Metrics
| Earnings Yield | -31.93% |
| Normalized Earnings Yield | -5.047 |